Envestnet Asset Management Inc. Has $1.43 Million Stock Position in ICU Medical, Inc. (NASDAQ:ICUI)

Envestnet Asset Management Inc. lowered its stake in ICU Medical, Inc. (NASDAQ:ICUIGet Rating) by 7.5% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 8,685 shares of the medical instruments supplier’s stock after selling 700 shares during the quarter. Envestnet Asset Management Inc.’s holdings in ICU Medical were worth $1,428,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in ICUI. Mutual of America Capital Management LLC raised its stake in ICU Medical by 1.8% during the 1st quarter. Mutual of America Capital Management LLC now owns 18,182 shares of the medical instruments supplier’s stock worth $4,048,000 after buying an additional 328 shares during the period. Comerica Bank raised its stake in ICU Medical by 21.8% during the 2nd quarter. Comerica Bank now owns 11,343 shares of the medical instruments supplier’s stock worth $1,917,000 after buying an additional 2,030 shares during the period. Treasurer of the State of North Carolina raised its stake in ICU Medical by 1.7% during the 1st quarter. Treasurer of the State of North Carolina now owns 7,340 shares of the medical instruments supplier’s stock worth $1,634,000 after buying an additional 123 shares during the period. Victory Capital Management Inc. raised its stake in ICU Medical by 3.6% during the 2nd quarter. Victory Capital Management Inc. now owns 17,279 shares of the medical instruments supplier’s stock worth $2,841,000 after buying an additional 597 shares during the period. Finally, Canvas Wealth Advisors LLC raised its stake in ICU Medical by 15.3% during the 1st quarter. Canvas Wealth Advisors LLC now owns 5,076 shares of the medical instruments supplier’s stock worth $1,066,000 after buying an additional 673 shares during the period. Institutional investors and hedge funds own 90.20% of the company’s stock.

Insider Activity

In other news, VP Virginia Ruth Sanzone sold 325 shares of the firm’s stock in a transaction dated Tuesday, November 15th. The stock was sold at an average price of $160.12, for a total value of $52,039.00. Following the completion of the transaction, the vice president now owns 3,046 shares in the company, valued at approximately $487,725.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 7.30% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

ICUI has been the subject of a number of research reports. StockNews.com upgraded ICU Medical from a “sell” rating to a “hold” rating in a report on Thursday, November 17th. KeyCorp lowered their target price on ICU Medical from $225.00 to $200.00 in a report on Tuesday, November 8th. Finally, Raymond James cut ICU Medical from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 8th.

ICU Medical Price Performance

Shares of NASDAQ ICUI opened at $157.93 on Tuesday. The stock has a market capitalization of $3.79 billion, a price-to-earnings ratio of -101.24 and a beta of 0.54. The business has a 50-day moving average of $151.13 and a 200-day moving average of $164.44. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.45 and a quick ratio of 1.17. ICU Medical, Inc. has a fifty-two week low of $128.90 and a fifty-two week high of $251.73.

About ICU Medical

(Get Rating)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.

See Also

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUIGet Rating).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.